You're watching...
New Cholesterol Drug on the Way?
Details
-
Description
FOXNewshealth.com managing editor Dr. Manny Alvarez on new drugs that could reduce bad cholesterol.
- Duration 2:52
- Date Mar 23, 2012
Advertisement
Clips
Also in this playlist...
Medical Dollars
Auto-advance: ON
Auto-advance-
New Cholesterol Drug on the Way?
-
CDC: Illnesses from Food Imports on the Rise
-
Why Pink Slime May Be in Your Child's School Lunch
-
Dr. Manny: Don't Be Afraid to Reach for a Diet Soda
-
CDC: Americans Consume Too Much Sodium
-
Pfizer Recalls a Million Packs of Birth Control Pills
-
One Little Pill the Key to Fighting Obesity, Diabetes?
-
Chinese Researchers Claim Internet Can Cause Brain Damage
-
How to Stock Up and Save on Meds
-
Report: Breast Cancer Vaccine Could Be Available in Three Years
-
Tips for Avoiding Holiday Heartburn
-
Intl Diabetes Federation: 552M Adults With Diabetes by 2030
Transcript
This transcript is automatically generated
-- -- on Twitter I'll tell you McConnell just called me right how about that's this year alone.
Die hard at what he says it's accurate it's it's a -- -- possible but this you to listen to a possible revolutionary development that could change the way we fight to lower cholesterol.
-- let's bring in -- -- for more on this.
-- Fox News health dot com Dr.
Manny.
Alvarez and as they document it is a big conference.
Over the weekend right.
And we we -- these medical conference is often move stocks -- companies that's very important from that bought a lot of stub is going to be moving five cholesterol games right coming to the -- near yeah that cholesterol games.
Look you know it'll this -- have been around their multi billion dollar drug business and the problem as is that we haven't had a new -- drug coming to market now.
And there seems to be very positive data.
On new drugs which are blockers and this is an enzyme -- pro team blocker called PC SK nine.
Are all looking at these types of blockers this -- -- Pacific enzyme blocking agent because what it does.
It really reduces the bad cholesterol but you know and all the study so far in the data wouldn't be presented in Chicago on Monday.
In the American cardiology association meeting.
But clearly shows that these drugs reduce 65%.
The HDL which is the bad cholesterol.
So when you look at you know -- you know look at the failure rates for many patients from the regular Staten you know the Lipitor -- this -- It can be as high as 40%.
So there's a huge market.
-- a lot of that a drug market.
Well it did did did did the big ticket item is gonna not now though they looked at the data initial data probably you gonna need a little bit larger studies I would say maybe.
No more than two years I given no more than two years.
Where you gonna be seen these medications and they're probably gonna start with a high risk population in I was population that has very very high cholesterol that really there's no treatment for right now.
And then it's gonna probably face out to general use.
But if it you know if it works as good as it does and it doesn't have the side effects as -- that things.
That call last -- all or some combination to a theater near you know and this is going to be a multibillion.
Dollar drug you know what I'm.
She sales go up at the same time why -- failed.
-- you -- -- -- take a dry and take residents -- bad cholesterol cynicism is overwhelming I didn't hear of that he has you have body -- -- -- -- the company's -- -- the world when you come along -- children's -- -- okay go ahead for crimes won't -- whatever we're working on her outlook on the world but it's only so much you can -- the fact that -- -- -- -- -- to say thank you so much -- -- and come back next thing talk about some more of these developments at that they cardiology meeting we will not know -- it will be a lot more talk about thank you can't try.
